OwlyTimes

#clinical-candidates

1 articles with this tag

Oculis reports $277.6M in cash to fund late-stage clinical trialsFinance

Oculis reports $277.6M in cash to fund late-stage clinical trials

Oculis holds $277.6 million in cash and investments as of March 31, 2026, to fund late-stage clinical trials and advance the OCS-01 development program.